Adams Diversified Equity Fund Inc. boosted its stake in The Allstate Co. (NYSE:ALL – Free Report) by 18.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 123,700 shares of the insurance provider’s stock after buying an additional 19,200 shares during the period. Allstate accounts for 0.9% of Adams Diversified Equity Fund Inc.’s portfolio, making the stock its 27th biggest holding. Adams Diversified Equity Fund Inc.’s holdings in Allstate were worth $23,848,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. State Street Corp boosted its position in shares of Allstate by 1.1% during the 3rd quarter. State Street Corp now owns 11,496,306 shares of the insurance provider’s stock valued at $2,190,758,000 after purchasing an additional 126,922 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Allstate by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,228,581 shares of the insurance provider’s stock valued at $1,178,164,000 after purchasing an additional 74,537 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of Allstate by 1.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,834,172 shares of the insurance provider’s stock valued at $353,610,000 after purchasing an additional 19,463 shares in the last quarter. Strategic Financial Concepts LLC boosted its position in shares of Allstate by 15,062.3% during the 4th quarter. Strategic Financial Concepts LLC now owns 1,119,129 shares of the insurance provider’s stock valued at $215,757,000 after purchasing an additional 1,111,748 shares in the last quarter. Finally, FMR LLC boosted its position in shares of Allstate by 11.8% during the 3rd quarter. FMR LLC now owns 933,352 shares of the insurance provider’s stock valued at $177,010,000 after purchasing an additional 98,179 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.
Insider Buying and Selling
In related news, CFO Jesse E. Merten sold 40,102 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the transaction, the chief financial officer now owns 18,115 shares in the company, valued at approximately $3,378,990.95. This represents a 68.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 1.80% of the stock is currently owned by corporate insiders.
Allstate Price Performance
Allstate (NYSE:ALL – Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 EPS for the quarter, topping analysts’ consensus estimates of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. Equities research analysts predict that The Allstate Co. will post 18.74 earnings per share for the current fiscal year.
Allstate declared that its Board of Directors has approved a stock repurchase plan on Wednesday, February 26th that authorizes the company to buyback $1.50 billion in outstanding shares. This buyback authorization authorizes the insurance provider to reacquire up to 3% of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s leadership believes its stock is undervalued.
Allstate Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Monday, March 10th will be issued a $1.00 dividend. The ex-dividend date is Monday, March 10th. This represents a $4.00 dividend on an annualized basis and a yield of 1.90%. This is an increase from Allstate’s previous quarterly dividend of $0.92. Allstate’s dividend payout ratio is currently 23.54%.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on the stock. Evercore ISI upgraded shares of Allstate from an “in-line” rating to an “outperform” rating in a research report on Wednesday, January 8th. Argus upgraded shares of Allstate from a “hold” rating to a “buy” rating in a research report on Monday, March 3rd. Barclays reduced their price objective on shares of Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a research report on Monday, January 6th. Piper Sandler upped their price objective on shares of Allstate from $206.00 to $244.00 and gave the company an “overweight” rating in a research note on Tuesday, November 26th. Finally, Wells Fargo & Company upped their price objective on shares of Allstate from $186.00 to $187.00 and gave the company an “equal weight” rating in a research note on Tuesday, January 14th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $217.94.
Read Our Latest Stock Analysis on ALL
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- Bank Stocks – Best Bank Stocks to Invest In
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- How to Most Effectively Use the MarketBeat Earnings Screener
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- How to Find Undervalued Stocks
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.